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The case of a 60-year-old male patient, who survived severe organophosphorus poisoning, and subsequently 
developed platypnoea and orthodeoxia is described. The patient was mechanically ventilated for a long period 
of time in the intensive care unit. During the weaning trial, he developed platypnoea and orthodeoxia (PaO, 
85 mmHg in recumbency, and 40 mmHg in upright position). Interestingly, the patient’s orthodeoxia was 
alleviated on continuous positive airway pressure (CPAP) treatment. This is a newly described cause of the 
platypnoea-orthodeoxia syndrome. The possible pathophysiological mechanisms are discussed and a review 
of the reported abnormal states associated with this condition is presented. 
Introduction 
Dyspnoea in the upright position that is relieved by 
resuming the supine posture was first described by 
Burchell et aI. (1) in 1949, and later Altman and 
Robin (2) coined the term ‘platypnoea’ (from the 
Greek words platys=recumbent and pnoezbreath). 
This is a rare form of dyspnoea and is usually accom- 
panied by arterial desaturation in the upright position 
that is improved during recumbency, a condition 
that is called orthodeoxia (from the Greek words 
orthos=upright and deoxia=desaturation). Both 
platypnoea and orthodeoxia have been described in 
patients with different underlying conditions (2-28) 
(Table 1). 
To our knowledge, the platypnoea-orthodeoxia 
couple has not been previously described in a patient 
with severe organophosphorus (OP) poisoning. 
Case Report 
A 60-year-old farmer was admitted to the intensive 
care unit after attempting suicide by ingesting an 
unknown quantity of the OP insecticide dimethoate 
2 h previously. On admission the patient was in deep 
coma, Glasgow coma scale (GCS) 4, had pinpoint- 
sized pupils and reduced muscle tone and tendon 
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reflexes. He was haemodynamically unstable with 
sinus bradycardia, (heart rate 45-55 beats min - ‘), 
multiple (>5 min - ‘) unifocal ventricular extra- 
systoles and hypotension (mean arterial pressure 
~60 mmHg). He also had severe cyanosis, gasping 
respirations and diffuse rales on chest ausculation. 
Chest radiography was normal and PaOJfraction of 




Shunts - intracardiac 414 
- peripheral 15 
Atria1 septal aneurysm 16 
Postpneumonectomy and postlobectomy 4,1419 
ARDS 20 
Diffuse parenchymal lung disease 21 
Autonomic dysfunction 22 
Ileus 23 
Amiodarone lung toxicity 24 
Eosinophilic endomyocardial disease 25 
Cirrhosis 2627 
Pulmonary embolii 4 
Constrictive pericarditis 28 
Organophosphorus poisoning Present case 
COPD, chronic obstructive pulmonary disease; ARDS, 
adult respiratory distress syndrome. 
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Fig. I Arterial blood saturation in sitting and supine positions, before and after CPAP. The desaturation in the sitting 
position was reversed by CPAP application. CPAP, continuous positive airways pressure. 
inspired oxygen taken after 1 h mechanical ventila- 
tion was 320. The abdominal wall was soft, there 
were increased bowel sounds and sialorrhea. Bouts of 
diarrhoea started 4 h after admission and lasted for 3 
days. The patient was intubated and resuscitated, and 
mechanical ventilation started. Atropine was given 
as boluses of 2 mg every 10 min up to 6 mg and 
subsequently continued as infusion of 0.016 to 
0.05 mg kg- i h ~ i for 23 days (cumulative dose 
649 mg). Pralidoxime (ZPAM) was given as boluses 
of 1 g 4 and 6 h after admission, and then as 500 mg 
q.i.d. for 12 days (cumulative dose 24 g). The dose 
of atropine was adjusted in order to: (i) minimize 
bronchial secretions; (ii) maintain pupil size as 
greater than 3 mm; and (iii) keep the heart rate 
greater than 100 beats min- ‘. The dose of pral- 
idoxime was also adjusted aiming to: (i) normalize 
acetylcholinesterase (Ache) serum levels, i.e. greater 
than 3.5 U 1 - ‘; and (ii) normalize the neuromuscular 
response, checked clinically and by a relaxograph 
(Datex, type 100-23-01, Finland). 
The remaining therapy included gastric lavage with 
activated charcoal and manitol every 3 h for the first 
24 h, until gastric lavage was free of poison. 
Laboratory results on admission were: haematocrit 
44%; Hb 14 g dl- ‘; serum urea 6 mm01 1 - i (reference 
values 2.2-9 mm01 1 - ‘); serum creatinine 133 mm01 l- ’ 
(range 65-141 mmol l- ‘); K+ 2.92 meq 1~ ’ (range 
3.5-5.5 meq 1 - ‘); Na+ 152 meq 1 - ’ (range 135- 
145 meq l- ‘); Ca2+ 2 mm01 1 - ’ (range 2.2- 
2.58 mmol 1 - ‘); aspartate aminotransferase (SGOT) 
70 U 1 - i (range 15-35 U 1 - I); alanine aminotrans- 
ferase (SGPT) 67 U 1 - ’ (range 9-39 U 1 - I); lactate 
dehydrogenase 500 U 1 - ’ (range 70-280 U 1 - ‘); and 
creatine kinase 280 U 1 - ’ (range 25-l 85 U 1 - I). 
The patient was evaluated twice daily by the same 
doctor for the severity of his condition (APACHE II 
score), central nervous system function (GCS score), 
respiratory function (Murray’s Acute Lung Injury 
score) (29), and the skeletal muscle function (clinical 
examination, relaxogram). 
The toxicological analysis for dimethoate quanti- 
tation by gas chromatography (30) in biological 
samples gave the following results: serum levels 
9.3pgml-‘, gastric fluid 18 mg ml ~ ’ and urine 
43 pug ml - ’ . Serum levels of dimethoate returned to 
non-toxic levels (<0,05pg ml- ‘) 15 days later. 
Ache serum levels on admission and during the 
following days determined spectrophotometrically 
(Boehringer Mannheim kit) are shown in Fig. 1. 
Plasma Ache activity on admission was 480 U 1 - ’ 
(reference values 3.5-8.5 U l- ‘), and reached the 
lower normal range on the twelfth hospital day. 
The course of the disease was prolonged, requiring 
mechanical ventilation for 30 days, atropine therapy 
for the first 23 days and pralidoxime administration 
for 12 days (Fig. 2). 
Clinical examination sho&d that the first skeletal 
muscle to recover was the diaphragm, followed 
by the muscles of the extremities. The intercostal 
muscles did not show any clinical activity and the 
patient had a diaphragmatic type of breathing. The 
weaning trial of the patient from the mechanical 
ventilation started 20 days after admission, initially 
on intermittent mandatory ventilation (IMV) mode, 
and 6 days later on continuous positive airways 
pressure (CPAP) (7.5-12.5 cm H,O) for 4 days. On 
the thirtieth day, after the patient had been stable for 
3 days breathing 40% 0, through a tracheostomy 
and a T-piece, he was put into the sitting position. 
Minutes later, he developed acute respiratory distress 
(tachypnoea, tachycardia, cold perspirations, upper 
chest inspiratory infold and severe cyanosis). Arterial 
PaO, dropped from 85 to 40 mmHg (SaO, from 95 
Orthodeoxia and platypnoea 627 
All the previously described causes and related 
abnormal states (Table 1) had been excluded in our 
patient. 
The proposed aetiologic mechanisms for the 
development of platypnoea-orthodeoxia include 
intracardiac (414,25), pulmonary vascular shunts 
[congenital (15) or acquired (26,27)] and severe 
ventilation-perfusion mismatch (2,3,22-24). 
Dimethoate (phosphorodithioic acid, 0,0-dimethyl 
ester), a systemic and contract organophosphorus 
insecticide is produced and marketed in Greece by 
various chemical companies under the trade names 
Dimephos, Dimethoate, Dimethol, Rogor, Roxion, 
all of them 40% solutions of the active compound. 
The reported LD,, value (orally in rats) is 
250mgkgg’. Three main types of neurotoxicity have 
been associated with OP agent poisoning (31): (1) The 
acute cholinergic crisis, which presents minutes to 
24 h after exposure, characterized by a combination 
of muscarinic, nicotinic and central nervous system 
signs and attributed to inhibition of carboxylic 
esterases. (2) The delayed neurotoxicity, a predomi- 
nantly motor polyneuropathy arising 2-3 weeks after 
the exposure and attributed to the inhibition of 
a separate esterase, termed the neuropathy target 
esterase. (3) The intermediate syndrome, appearing 
2-5 days after the acute crisis, characterized by acute 
respiratory distress and skeletal muscles weakness, 
which coincides with prolonged cholinesterase inhibi- 
tion resistant to atropine and oximes treatment. 
Although it is obvious that the patient developed a 
severe and protracted intermediate syndrome after an 
acute cholinergic crisis both due to OP poisoning, the 
reason for platypnoea-orthodeoxia is not clear. One 
possible explanation is the earlier resuming of activity 
of the diaphragm in relation to intercostal muscles. 
However, this is based only on the observation of the 
diaphragmatic type of breathing of the patient. It has 
been shown that selective contraction of different 
respiratory muscles may result in changes in the 
vertical gradient of pleural surface pressure and lung 
volume, although in normal subjects it appears to be 
more prominent in the horizontal positions (32-33). 
In support of this as a cause of platypnoea- 
orthodeoxia is the improvement of oxygen saturation 
on the patient’s placement on face CPAP, an obser- 
vation that has not been reported previously. Indeed, 
small airways closure or microatelectasis has been 
suggested as the cause of the observed ventilation- 
perfusion mismatch in platypnoea-orthodeoxia (22) 
which may have reversed by applying CPAP. 
Another explanation could by the automatic nerv- 
ous system dysfunction as a result of OP poisoning. 
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Fig. 2 A summary of the patient’s intrahospital course. 
Plasma acetyl cholinesterase levels, modes of treatment and 
their duratibn as well as the duration of the platypnoea- 
orthodeoxia are depicted. IPPV, intermittent positive pres- 
sure ventilation; IMV, intermittent mandatory ventilation; 
CPAP, continuous positive airways pressure; AV, assisted 
ventilation; P-0, platypnoea-orthodeoxia. 
to 70%). The systemic arterial pressure didn’t change 
significantly and the patient recovered by resuming 
the supine position. The same episode was induced 
and repeated whenever the patient was put in the 
sitting position (orthodeoxia) and was relieved in the 
supine position (platypnoea). Interestingly, the syn- 
drome was totally alleviated by simple substitution of 
a T-piece to CPAP (7.5 cm H,O) (Fig. 1). No change 
in PaO, was noted in left or right decubitus positions. 
This condition lasted to a progressively lesser degree 
for the following 2 weeks. Echocardiography 
revealed normal left ventricular systolic function. A 
tilt-table two-dimensional contrast echocardiography 
did not demonstrate a shunt. A proposed cardiac 
catheterization and pulmonary angiography was 
denied by the patient. The patient’s hospital course is 
summarized in Fig. 2. 
The patient was discharged 45 days after admis- 
sion, much improved, without symptoms of platyp- 
noea or orthodeoxia, and with no need for 
supplemental oxygen. After 4 months, he was able to 
return to work. 
Discussion 
This report documents a 60-year-old man who 
developed platypnoea and orthodeoxia after 
mechanical ventilation for severe OP poisoning. To 
our knowledge, this is the first case of platypnoea and 
orthodeoxia described in relation to this condition. 
628 D. Bouros et al. 
autonomic failure followed by a decrease in blood 14. 
pressure, inadequate perfusion of the upper lung and 
increased zone I, result in ventilation-perfusion mis- 
match, hypoxaemia and dyspnoea (22,24,28). This 
15. 
seems impossible in our case because the blood 
pressure was stable even after the CPAP application. 16. 
An intracardiac shunt as a possible cause of 
platypnoea-orthodeoxia was excluded by contrast 
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